Case Study 1 — Walt Goes for Remission: Eleven Years, and the Question Nobody Asked
Walt Prosser is an illustrative composite carried through this book — Chapter 11 (the fibre ramp), Chapter 13 (B12), Chapter 16 (the supplement audit and the biotin–troponin ER visit), and here. ⚠️ The remission protocol, the dose-response and the medication management are real; the person is constructed. ⚠️ This describes a supervised clinical intervention, not a self-directed one.**
Setup
Walt is 68. Type 2 diabetes for eleven years.
| A1c | 6.9% (down from 7.4% after Chapters 11 and 16) |
| Weight | 103 kg, BMI 33.6 |
| Waist | ⚠️ 116 cm — never previously measured |
| Medication | Metformin 1 g twice daily |
| BP | 148/88 |
| Triglycerides | 2.6 mmol/L |
| ALT | ⚠️ 61 U/L — flagged on three previous panels, never explained to him |
| Lp(a) | ⚠️ 92 nmol/L — never measured until now |
He came in about his knees.
⚠️ And in eleven years of appointments, nobody had ever said the word "remission" to him.
The conversation that changed it
He asked what he thought was a resigned question:
"It just gets worse, doesn't it. That's what diabetes does."
⚠️ That is what he had understood for eleven years, and it is what the structure of his care had implied — annual reviews, medication escalation, and the word "progressive."
The answer:
"Sometimes. Not always. There's a reasonable chance you could come off medication entirely — and we can tell you roughly what it would take."
⚠️ Then the numbers, from §26.3:
| ⚠️ Weight lost | ⚠️ Remission at 12 months, in DiRECT |
|---|---|
| ≥15 kg | ~86% |
| 10–15 kg | ~57% |
| 5–10 kg | ~34% |
| <5 kg | ⚠️ ~7% |
Walt looked at the table for a while and said:
"So it's not 'lose some weight and see.' There's a number."
⚠️ That is the entire value of the dose-response gradient, and it is why §26.3 argues it matters more than the headline remission rate.
The two honest cautions he was given first
1. ⚠️ Duration. Eleven years is longer than DiRECT's recruitment window of up to six. Remission is less likely with longer duration, because beta-cell function is less recoverable.
⚠️ He was told this explicitly, before starting, with a number attached: "Your chances are lower than those figures. I don't know by how much. It's still worth trying if you want to."
2. ⚠️ Medication. He was on metformin only, which is low hypoglycaemia risk — ⚠️ but the protocol still required prescriber involvement, and his blood pressure medication needed monitoring because it commonly requires reduction as weight falls.
⚠️ Had he been on gliclazide or insulin, this would have been a different and considerably more carefully managed conversation (§26.4). A person on a sulfonylurea who starts an 850 kcal formula diet without medication adjustment is at real risk of hypoglycaemia, and it can be severe.
What he actually did
A structured programme, supervised:
| Phase | ||
|---|---|---|
| 1 | ⚠️ Total diet replacement — formula products, ~850 kcal/day, ~12 weeks | Metformin stopped at start; BP medication reviewed |
| 2 | Structured food reintroduction — ~6 weeks, stepwise | Weight monitored weekly |
| 3 | ⚠️ Long-term maintenance support — monthly contact, then quarterly | The phase that determines whether it holds (Chapter 24 §24.2) |
⚠️ What he found hardest, in his words:
Weeks 1–2: "Genuinely horrible. I thought about food constantly." Weeks 3–12: "It got easier around day ten. Then it was just boring." ⚠️ Reintroduction: "This was the frightening bit. I'd stopped trusting myself with food."
⚠️ That last line is why phase 2 is structured rather than "go back to normal" — Chapter 24 Case Study 1's age-39 attempt failed precisely there.
The numbers, in the order they moved
⚠️ §26.13b, observed.
| Week | What changed |
|---|---|
| 1 | ⚠️ Blood glucose fell immediately — before meaningful weight loss. This is the liver responding, not the fat coming off |
| 2 | Blood pressure down; ⚠️ BP medication reduced |
| 3 | ⚠️ Triglycerides 2.6 → 1.4 mmol/L |
| 8 | ⚠️ ALT 61 → 34 U/L — liver fat, the fastest structural change available |
| 12 | ⚠️ A1c 6.9% → 5.7% — first meaningful reading, as expected |
| 12 | Weight 103 → 88 kg (−15 kg) |
| Waist | ⚠️ 116 → 101 cm |
💡 Aha moment. ⚠️ Glucose improved in week one, before the weight did.
This surprises almost everyone, and it is §26.1b's mechanism showing itself: the earliest effect of severe energy restriction is a rapid fall in LIVER fat, which reduces hepatic glucose output.
⚠️ The pancreas takes longer. The scale takes longer still. Which means "nothing's happening yet" in week two is usually wrong — the wrong thing is being measured.
At 12 months
| Baseline | 12 months | |
|---|---|---|
| Weight | 103 kg | ⚠️ 91 kg (regained 3 from the nadir) |
| A1c | 6.9% | ⚠️ 5.9%, off all diabetes medication |
| ⚠️ Remission status | — | ⚠️ Achieved and maintained |
| BP | 148/88 | 128/78, on a reduced dose |
| Triglycerides | 2.6 | 1.3 |
| ALT | 61 | 29 |
| Waist | 116 cm | 103 cm |
| ⚠️ Lp(a) | 92 nmol/L | ⚠️ 91 nmol/L |
⚠️ Read the last row.
Everything on that panel moved except the one thing that was never going to.
⚠️ And knowing that in advance mattered — because when the Lp(a) came back unchanged, Walt did not conclude the programme had failed. He had been told at the start which number was tier 4 (§26.1).
What his Lp(a) did change: his cardiovascular risk is higher than his other numbers suggest, so everything else is now managed more aggressively — including a statin, which he takes without regarding it as a defeat.
Analysis
1. ⚠️ Eleven years, and nobody had said "remission." The single most consequential fact in the case.
2. The dose-response table converted a vague goal into a target. ⚠️ "There's a number" is what made him agree.
3. ⚠️ He was told his chances were lower than the trial figures, before starting. Duration matters, and setting the expectation honestly is what allows a partial result to feel like a result.
4. ⚠️ Glucose moved in week one, before the weight. Liver fat first, pancreas later, scale later still — §26.1b's mechanism, visible.
5. The reintroduction phase was the frightening part, and it is where unsupported programmes fail (Chapter 24 Case Study 1).
6. ⚠️ He regained 3 kg and remained in remission. Remission is not all-or-nothing at a single weight, and framing it that way would have made a good outcome feel like a failure.
7. ⚠️ Lp(a) didn't move, and he had been warned. The forewarning is what stopped an unchanged number from discrediting a successful intervention.
8. And his ALT — flagged on three panels over several years — had never been explained. ⚠️ Fatty liver was the most reversible thing on his chart and nobody had named it.
Discussion Questions
-
⚠️ Eleven years without the word "remission." Why? Give a structural explanation, not a blaming one — and say what would have to change in how diabetes reviews are conducted.
-
DiRECT recruited people diagnosed within six years; Walt was at eleven. ⚠️ Was offering him the programme justified? How should evidence be extrapolated beyond its recruitment criteria?
-
⚠️ He was told his chances were lower and given no number. Is "I don't know by how much" good practice or an evasion? What would you have said?
-
Glucose moved before weight. ⚠️ How much of medicine's messaging about diabetes would change if this were widely understood?
-
⚠️ He regained 3 kg and stayed in remission. How should remission be defined and monitored so that normal weight fluctuation doesn't read as failure?
-
His ALT was flagged three times and never explained. ⚠️ Design the system change. What stops an abnormal result from being noted and ignored?
Your Turn
⚠️ This is for anyone with type 2 diabetes or prediabetes, or anyone advising someone who has.
Step 1 — Establish the basics:
Years since diagnosis: ____ (⚠️ shorter is better for remission) Current A1c: _ · Weight: _ kg · Waist: ____ cm ⚠️ Medications, specifically: any insulin or sulfonylurea? ____
Step 2 — Find your number. ⚠️ Using §26.3's gradient:
| Weight loss | From my current weight, that means | Remission likelihood |
|---|---|---|
| 5% | ____ kg | Low |
| 10% | ____ kg | Moderate |
| ⚠️ 15 kg or more | ____ | ⚠️ Highest |
Step 3 — ⚠️ The question to take to your appointment:
"Am I a candidate for remission, and how much weight loss would it take in my case?"
⚠️ If the answer is no, ask why — duration, beta-cell reserve, other conditions. A reason is useful. Silence isn't.
Step 4 — Sort your panel by §26.1's tiers, and ⚠️ specifically ask whether your Lp(a) has ever been measured.
Step 5 — ⚠️ The safety step, and it is not optional:
If you take insulin or a sulfonylurea, you must speak to your prescriber BEFORE reducing carbohydrate or energy intake. Not after. Not "I'll mention it at my review."
Step 6 — And write the maintenance plan before the loss plan (Chapter 24 §24.14).
⚠️ "What will I still be doing in three years?"
Walt's answer was: weigh weekly, walk the dog, cook five nights, and a quarterly appointment he doesn't cancel. ⚠️ Four things, none of them a diet.